Appointment Announcement – Jamie Moss, Executive Chair
We’re excited to announce the appointment of Jamie Moss, new Executive Chair.
We’re excited to announce the appointment of Jamie Moss, new Executive Chair.
Join our ICH E6(R3) live panel webinar, explore ACRO highlights, and connect with TRI this autumn.
ICH E6(R3) is now effective in the EU, marking a pivotal shift in clinical trial oversight. This issue breaks down what it means and how to stay ahead.
TRI’s reimagined OPRA-CM platform delivers on the true promise of RBQM, cutting through complexity to enable smarter, faster, and more focused centralized monitoring.
In this edition, we mark National Clinical Trials Day, spotlight new Tufts CSDD research on monitoring trends, and share must-attend events.
From Vancouver to London, this edition highlights must-attend RBQM events that offer fresh insights, regulatory updates, and real-world strategies to elevate your clinical trial oversight.
We’re heading to Brussels for SCDM 2025 EMEA! Visit TRI at Booth 21 to discover how our reimagined OPRA-CM platform is transforming centralized monitoring and driving RBQM success.
In this edition, we reflect on two standout events, RBQM Summit and SCOPE 2025.
We spotlight major developments in clinical research, from new FDA biopsy guidance and the EU’s CTIS transition deadline.